Independent reporting and analysis across technology, science, startups and invention.
Beam activates 23 billion parameters at a time and targets coding and agentic work, but its weights, model card and technical report are still promised for later in October.
Read story
The global partnership will fund later-stage testing of lixudebart across rare kidney and liver diseases. Its anti-fibrotic promise remains unproven in a pivotal trial.
Read story
The Kyoto Vision backs new research-funding models, wider access to AI and stronger scientific integrity. It is a political signal rather than a funded or binding implementation plan.
Read story
Novartis will pay $575 million upfront for worldwide rights to ABO2203 and options on other Abogen RNA programs. The much larger headline figure depends on development, approvals and commercialization that may never occur.
Read story
A Delaware judge ruled that the federal government’s license to university inventions does not automatically protect a private supplier. Moderna’s separate government-contract defense—and the underlying infringement claims—remain unresolved.
Read story
A task force led by U.S. intelligence chief Jay Clayton will examine AI risks, opportunities and the federal government’s role. Its short mandate raises an immediate test: whether it can turn broad coordination into verifiable policy.
Read story
The Eighth Circuit has paused enforcement of a first-of-its-kind state law aimed at AI tools that generate realistic intimate images of identifiable people. The injunction is temporary and does not settle the constitutional dispute.
Read story
A prospective convertible facility disclosed in Anthropic’s IPO papers shows how AI infrastructure is becoming a financing structure as well as a technology stack. The $42 billion is a ceiling, not money already borrowed or spent.
Read story
A Delaware lawsuit adds JA Solar companies and American Panel Solutions to a growing dispute over a manufacturing patent for high-efficiency crystalline-silicon cells. The filing could test how broadly one of solar's most commercially important process portfolios reaches.
Read story